Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Coexpression of stemness factors Oct4 and Nanog predict liver resection.

Yin X, Li YW, Zhang BH, Ren ZG, Qiu SJ, Yi Y, Fan J.

Ann Surg Oncol. 2012 Sep;19(9):2877-87. doi: 10.1245/s10434-012-2314-6. Epub 2012 Mar 30.

PMID:
22461131
2.
3.

Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.

Cheng SW, Tsai HW, Lin YJ, Cheng PN, Chang YC, Yen CJ, Huang HP, Chuang YP, Chang TT, Lee CT, Chao A, Chou CY, Chan SH, Chow NH, Ho CL.

PLoS One. 2013 Nov 14;8(11):e80053. doi: 10.1371/journal.pone.0080053. eCollection 2013.

4.

Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression.

Chang TS, Wu YC, Chi CC, Su WC, Chang PJ, Lee KF, Tung TH, Wang J, Liu JJ, Tung SY, Kuo LM, Ho HN, Ling TY, Huang YH.

Clin Cancer Res. 2015 Jan 1;21(1):201-10. doi: 10.1158/1078-0432.CCR-13-3274. Erratum in: Clin Cancer Res. 2016 Dec 15;22(24):6303.

5.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
6.
7.

A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.

Zhu P, Jin J, Liao Y, Li J, Yu XZ, Liao W, He S.

Oncotarget. 2015 Dec 1;6(38):41383-97. doi: 10.18632/oncotarget.5510.

9.

Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.

Zheng H, Yang Y, Wang MC, Yuan SX, Tian T, Han J, Ni JS, Wang J, Xing H, Zhou WP.

Surg Oncol. 2016 Sep;25(3):171-7. doi: 10.1016/j.suronc.2016.05.026. Epub 2016 May 24.

PMID:
27566019
10.

Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma.

Dong Z, Zeng Q, Luo H, Zou J, Cao C, Liang J, Wu D, Liu L.

Pathol Res Pract. 2012 Sep 15;208(9):527-33. doi: 10.1016/j.prp.2012.05.019. Epub 2012 Jul 21.

PMID:
22824146
11.

High expression of CCL20 is associated with poor prognosis in patients with hepatocellular carcinoma after curative resection.

Ding X, Wang K, Wang H, Zhang G, Liu Y, Yang Q, Chen W, Hu S.

J Gastrointest Surg. 2012 Apr;16(4):828-36. doi: 10.1007/s11605-011-1775-4. Epub 2011 Nov 10.

PMID:
22072303
12.

[OCT4 expression in hepatocellular carcinoma and its clinical significance].

Huang PZ, Lu CL, Li BK, Hong J, Huang L, Wang L, Zhang Y, Yuan YF.

Chin J Cancer. 2010 Jan;29(1):111-16. Chinese.

13.

Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.

Tsuchiya K, Komuta M, Yasui Y, Tamaki N, Hosokawa T, Ueda K, Kuzuya T, Itakura J, Nakanishi H, Takahashi Y, Kurosaki M, Asahina Y, Enomoto N, Sakamoto M, Izumi N.

Oncology. 2011;80(3-4):278-88. doi: 10.1159/000328448. Epub 2011 Jul 7.

PMID:
21734420
14.

High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.

Hu J, Xu Y, Shen ZZ, Wang Z, Lu Q, Yang GH, Ding ZB, Fan J, Zhou J.

J Cancer Res Clin Oncol. 2009 Oct;135(10):1359-67. doi: 10.1007/s00432-009-0577-5. Epub 2009 Apr 7. Erratum in: J Cancer Res Clin Oncol. 2009 Nov;135(11):1635-6.

PMID:
19350273
15.

Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.

Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD.

World J Gastroenterol. 2015 Jun 7;21(21):6649-59. doi: 10.3748/wjg.v21.i21.6649.

16.

Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.

Chang TS, Chen CL, Wu YC, Liu JJ, Kuo YC, Lee KF, Lin SY, Lin SE, Tung SY, Kuo LM, Tsai YH, Huang YH.

PLoS One. 2016 Feb 26;11(2):e0149897. doi: 10.1371/journal.pone.0149897. eCollection 2016. Erratum in: PLoS One. 2017 Jan 26;12 (1):e0171176.

17.

Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.

Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY.

Liver Transpl. 2014 Aug;20(8):945-51. doi: 10.1002/lt.23904. Epub 2014 Jul 12.

18.

Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.

Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.

World J Gastroenterol. 2015 Apr 7;21(13):3983-93. doi: 10.3748/wjg.v21.i13.3983.

19.

The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.

Chen R, Cui J, Xu C, Xue T, Guo K, Gao D, Liu Y, Ye S, Ren Z.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S375-84. doi: 10.1245/s10434-011-1836-7. Epub 2011 Jun 17.

PMID:
21681378
20.

Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.

Tsai LL, Yu CC, Chang YC, Yu CH, Chou MY.

J Oral Pathol Med. 2011 Sep;40(8):621-8. doi: 10.1111/j.1600-0714.2011.01015.x. Epub 2011 Feb 22.

PMID:
21342274

Supplemental Content

Support Center